Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Apr;30(4):330, 333.

Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach

Brian A Jonas, Bruno C Medeiros
Comment

Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach

Brian A Jonas et al. Oncology (Williston Park). 2016 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Jonas BA, Medeiros BC. Clinical presentation of acute myeloid leukemia. In: Garza JM, editor. Acute myeloid leukemia: signs/symptoms, classification and treatment options. Hauppauge, NY: Nova Science Publishers, Inc; 2015. pp. 1–34.
    1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51. - PubMed
    1. Mrozek K, Marcucci G, Nicolet D, et al. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012;30:4515–23. - PMC - PubMed
    1. Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079–89. - PMC - PubMed
    1. Khaled S, Al Malki M, Marcucci G. Acute myeloid leukemia: biologic, prognostic, and therapeutic insights. Oncology (Williston Park) 2016;30:318–29. - PubMed

Publication types

MeSH terms